Botox approved for crow's feet

The licence for Botox has been extended

The licence for Botox (botulinum toxin type A) has been extended to include temporary improvement in the appearance of moderate to severe crow's feet seen at maximum smile, when these have an important psychological impact.1

Botox is reconstituted to a concentration of 50 units/1.5ml, and three 0.1ml injections are given into the lateral orbicularis oculi muscle on each side, for a total dose of 24 units. For patients who also have glabellar lines causing psychological effects, these may be treated at the same time.1

Improvement generally occurs within one week after treatment and lasts for up to four months. Treatment intervals should not be less than three months.1

Reference

1. Botox Summary of Product Characteristics, January 2014.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

New once-weekly GLP-1 agonist for diabetes

New once-weekly GLP-1 agonist for diabetes

Ozempic (semaglutide) is a glucagon-like peptide-1...

Gluten-free prescribing restricted to bread and mixes

Gluten-free prescribing restricted to bread and mixes

GPs in England are no longer able to prescribe gluten-free...

New vitamin D deficiency thresholds recommended

New vitamin D deficiency thresholds recommended

The National Osteoporosis Society (NOS) has updated...

SGLT2 inhibitors associated with increased risk of lower-limb amputation in new study

SGLT2 inhibitors associated with increased risk of lower-limb amputation in new study

SGLT2 inhibitors may be linked to a doubling in the...